Masthead Image

Nicholas Onaca, M.D.

Onaca

Medical School:
Carol Davilla University of Medicine and Pharmacy, Bucharest, Romania

Internship:
The University Hospital of Bucharest, Romania

Residency:
General Surgery - Department of Surgery, Sheba Medical Center, Tel Hashomer, Israel

Fellowships:
Liver Transplantation - Mayo Clinic, Rochester, MN
Transplant Surgery - Baylor University Medical Center at Dallas
Transplant Surgery/Islet Cell Transplantation - Baylor University Medical Center

Professional Memberships:
The American Medical Association
The American Society of Transplantation
American Society of Transplant Surgeons
International Liver Transplant Society
The Israeli Medical Association
Israeli Society for Organ Transplantation
Mayo Medical Alumni Association

 

 

Other Links

For more information call:214-820-2050

Research & Clinical Trials

Baylor Research Institute

A Phase 2, Randomized, Open-Label, Parallel Group, Multi-Center Study To Assess the Safety and Efficacy of Alefacept in De Novo Kidney Transplant Recipients

Acute Renal Failure Post Liver Transplantation: The Role of Cytokines and Oxidative Stress

A Phase II Trial To Assess the Safety of Immunosuppression Withdrawal In Liver Transplant Recipients

Diagnostic and Therapeutic Development for Infectious Diseases

Evaluation of HepaGam B®in Combination with Antiviral Treatment in Hepatitis B Liver Transplant Patients

A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy, Safety and Tolerability of AST-120 (Spherical Carbon Adsorbent) for 8 Weeks in the Treatment of Mild Hepatic Encephalopathy

Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation, Part A

A 24 Month Multi-Center Randomized, Open Label Study to Evaluate the Efficacy and Safety of Concentration Controlled Everolimus with Corticosteroids in Combination with Minimization or Elimination of Tacrolimus in de novo Liver Transplant Recipients Compared to Tacrolimus and Corticosteroids

 

 

Physicians are employees of HealthTexas Provider Network and are neither employees nor agents of Baylor Health Care System, Baylor University Medical Center or Baylor Health Care System’s subsidiary, community or affiliated medical centers. ©2009 Baylor Health Care System